Investors & Media International Stem Cell Corporation and Absorption Systems Announce Potential Stem Cell Alternative to Live Animal Testing for Corneal Damage International Stem Cell Corporation Issues Letter to Shareholders International Stem Cell Corporation Adds Strength Through Expansion of its Management Structure International Stem Cell Corporation Secures $5 Million Financing Commitment International Stem Cell Corporation Reports Positive Pre-Clinical Trial Results From Human Corneal Epithelial Cells International Stem Cell Corporation Provides Comments on National Institutes of Health's Proposed Stem Cell Research Guidelines International Stem Cell Corporation Announces the Release of DataTrends Equity Research Group Investor's Corporate ProfileŽ of the Company International Stem Cell Reports Excellent Preliminary Results for Skin Rejuvenation International Stem Cell Corporation Receives Third $1M Tranche under a $5 Million Financing International Stem Cell Corporation enters into an Agreement with Cytograft Tissue Engineering to Develop a Therapeutic Medium for Cytograft's Living Vascular Grafts 24 25 26 27 28 29 30 31 32 33 34 << < > >>
